Click here for more information about preventive HIV vaccines [clinicaltrials_resource:1df337d06c19fe2a99c318c167fafb09]
A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT) [clinicaltrials:NCT00000751]A Study of the Effects of Giving Two Anti-HIV Vaccines to Babies of HIV-Positive Mothers [clinicaltrials:NCT00000879]A Study to Monitor the Health of Participants in HIVNET 014 Who Become Infected With HIV-1 [clinicaltrials:NCT00001121]Safety and Immune Response Study of the Vaccine ALVAC vCP1452 Alone or in Combination With AIDSVAX B/B [clinicaltrials:NCT00007332]Safety and Effectiveness of the Vaccine ALVAC-HIV vCP205 in HIV-Negative Adult Volunteers in Uganda [clinicaltrials:NCT00007423]ALVAC-HIV vCP1452 Alone and Combined With MN rgp120 [clinicaltrials:NCT00011037]Safety and Immune Response Study of High-Dose Canarypox ALVAC-HIV Vaccine in Healthy, HIV Uninfected Adults [clinicaltrials:NCT00027261]An Investigational Combination Vaccine Given to People Who Are Not Infected With HIV [clinicaltrials:NCT00027365]A Study to Prepare for Future HIV Vaccine Studies [clinicaltrials:NCT00029744]The Effectiveness of Human Antibodies in Influencing an AIDS-Like Disease in Monkeys [clinicaltrials:NCT00031109]Evaluation of the Safety of and Immune Response to an HIV Vaccine in Healthy Adults [clinicaltrials:NCT00051454]Development of a New HIV Vaccine [clinicaltrials:NCT00051922]Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Uninfected Adults [clinicaltrials:NCT00054860]Determining an Effective Site (Groin Versus Arm) for Giving HIV Vaccines [clinicaltrials:NCT00056745]Safety of and Immune Response to Polyvalent HIV-1 Vaccine in HIV Uninfected Adults [clinicaltrials:NCT00061243]Safety of an HIV Vaccine (AVX101) in HIV Uninfected Volunteers in the United States and South Africa [clinicaltrials:NCT00063778]Analysis of Immune Responses to HIV Vaccines [clinicaltrials:NCT00068978]Safety of and Immune Response to an HIV Vaccine (VRC-HIVDNA009-00-VP) Administered With Interleukin-2/Immunoglobulin (IL-2/Ig) DNA Adjuvant in Uninfected Adults [clinicaltrials:NCT00069030]Safety of and Immune Response to an HIV-1 DNA Vaccine (VRC HIVDNA009-00-VP) in HIV Uninfected Adults [clinicaltrials:NCT00071851]Safety of and Immune Response to a New HIV Vaccine: HIV CTL MEP [clinicaltrials:NCT00076037]A Study of LIPO-5 and ALVAC-HIV (vCP1452) as Possible HIV Vaccines [clinicaltrials:NCT00076063]Safety and Effectiveness of Administering an HIV Vaccine in the Groin Versus the Arm [clinicaltrials:NCT00076817]Safety of the EnvPro HIV Vaccine in Healthy Volunteers [clinicaltrials:NCT00076947]Safety of and Immune Response to an HIV-1 Subtype C Vaccine (AVX101) in HIV Uninfected Adults [clinicaltrials:NCT00097838]Safety of and Immune Response to an HIV-1 Vaccine (ALVAC-HIV vCP1521) in Infants Born to HIV Infected Mothers [clinicaltrials:NCT00098163]Study of an HIV Preventive Vaccine Given With or Without an Adjuvant in HIV Uninfected Adults [clinicaltrials:NCT00111605]Safety of and Immune Response to an HIV Preventive Vaccine (HIV-1 Gag DNA Alone or With IL-15 DNA) Given With or Without 2 Different Booster Vaccinations in HIV Uninfected Adults [clinicaltrials:NCT00115960]Safety of and Immune Response to an Experimental HIV Vaccine (VRC-HIVADV014-00-VP) in HIV Uninfected Adults [clinicaltrials:NCT00119873]Safety of and Immune Response to an HIV-1 Vaccine (VRC-HIVDNA016-00-VP) and a Vaccine Booster (VRC-HIVADV014-00-VP) in HIV Uninfected East African Adults [clinicaltrials:NCT00123968]Safety of and Immune Response to an Adenoviral HIV Vaccine (VRC-HIVADV014-00-VP) With or Without a Plasmid HIV Vaccine (VRC-HIVDNA016-00-VP) in HIV Uninfected Adults [clinicaltrials:NCT00124007]Safety of and Immune Response to a DNA HIV Vaccine Followed By an Adenoviral Vector HIV Vaccine in Healthy Adults [clinicaltrials:NCT00125970]Safety of and Immune Response to the Experimental Preventive HIV Vaccine, EP HIV-1090, in Healthy, HIV-1 Uninfected Adults [clinicaltrials:NCT00141024]Safety of and Immune Response to Two Different HIV Vaccines, Each Followed by a Adenoviral Vaccine Boost, in HIV Uninfected Adults [clinicaltrials:NCT00270218]clinicaltrials:NCT00301184clinicaltrials:NCT00384787clinicaltrials:NCT00413725Safety of and Immune Response to an HIV DNA Plasmid Vaccine Followed by HIV Adenoviral Vector Vaccine in Healthy African Adults [clinicaltrials:NCT00415649]clinicaltrials:NCT00472719clinicaltrials:NCT00486408Safety and Effectiveness of an HIV DNA Vaccine Followed by an HIV Adenoviral Vector Vaccine for Prevention of HIV Infection in the Americas and Africa [clinicaltrials:NCT00498056]
link [clinicaltrials_vocabulary:link]
Click here for more information about preventive HIV vaccines [clinicaltrials_resource:1df337d06c19fe2a99c318c167fafb09]
Bio2RDF identifier
1df337d06c19fe2a99c318c167fafb09
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:1df337d06c19fe2a99c318c167fafb09
url [clinicaltrials_vocabulary:url]
identifier
clinicaltrials_resource:1df337d06c19fe2a99c318c167fafb09
title
Click here for more information about preventive HIV vaccines
@en
Click here for more information on HIV preventive vaccines
@en
Click here for more information on preventive HIV vaccines
@en
type
label
Click here for more informatio ...... 337d06c19fe2a99c318c167fafb09]
@en
Click here for more informatio ...... 337d06c19fe2a99c318c167fafb09]
@en
Click here for more informatio ...... 337d06c19fe2a99c318c167fafb09]
@en